Belite Bio (BLTE) Tax Rate (2023 - 2024)
Belite Bio (BLTE) posted quarterly Tax Rate of 0.07% for Q3 2024, up 8.0% year-over-year from 0.06% in Q4 2023, and up 190.53% on a QoQ basis from 0.08% in Q1 2024.
Belite Bio (BLTE) Tax Rate (2023 - 2024) Analysis & Trends
Belite Bio (BLTE) has reported Tax Rate for 2 consecutive years, with 0.07% the latest figure, recorded in Q3 2024.
- In Q3 2024, Tax Rate rose 8.0% year-over-year to 0.07%; the TTM figure through Dec 2024 stood at 0.0% (up 7.0% YoY), while the FY2024 annual figure was 0.02%, up 49.0% from the prior year.
- Tax Rate came in at 0.07% for Q3 2024 at Belite Bio, up from 0.08% in the prior quarter.
- The five-year high for Tax Rate was 0.07% in Q3 2024, with the low at 0.09% in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | - |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | 5.61% |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 12.29% |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 17.68% |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | 9.35% |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 12.51% |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 13.70% |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 7.07% |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | - |
| 10 | Belite Bio | 96.77 Mn | 96.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 0.07 |
| Sep 30, 2024 | 0.07 |
| Mar 31, 2024 | -0.08 |
| Mar 31, 2024 | -0.08 |
| Dec 31, 2023 | 0.01 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | -0.01 |
| Sep 30, 2023 | -0.01 |
| Jun 30, 2023 | -0.04 |
| Jun 30, 2023 | -0.04 |
| Mar 31, 2023 | -0.09 |
| Mar 31, 2023 | -0.09 |